TIAA CREF Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $14.5M | Buy |
178,392
+65,134
| +58% | +$5.29M | 0.01% | 856 |
|
2018
Q4 | $6.12M | Sell |
113,258
-184,145
| -62% | -$9.96M | ﹤0.01% | 1250 |
|
2018
Q3 | $15.3M | Sell |
297,403
-6,204
| -2% | -$320K | 0.01% | 871 |
|
2018
Q2 | $12.7M | Sell |
303,607
-7,720
| -2% | -$322K | 0.01% | 999 |
|
2018
Q1 | $13.7M | Sell |
311,327
-9,851
| -3% | -$434K | 0.01% | 939 |
|
2017
Q4 | $16.2M | Sell |
321,178
-17,027
| -5% | -$856K | 0.01% | 884 |
|
2017
Q3 | $17.1M | Sell |
338,205
-26,412
| -7% | -$1.34M | 0.01% | 835 |
|
2017
Q2 | $18.5M | Buy |
364,617
+5,168
| +1% | +$263K | 0.01% | 797 |
|
2017
Q1 | $14.5M | Sell |
359,449
-8,251
| -2% | -$332K | 0.01% | 899 |
|
2016
Q4 | $17.6M | Sell |
367,700
-15,460
| -4% | -$739K | 0.01% | 808 |
|
2016
Q3 | $14K | Buy |
383,160
+20,521
| +6% | +$752 | 0.01% | 931 |
|
2016
Q2 | $8.45M | Sell |
362,639
-1,357
| -0.4% | -$31.6K | 0.01% | 1160 |
|
2016
Q1 | $14.7M | Sell |
363,996
-17,435
| -5% | -$706K | 0.01% | 865 |
|
2015
Q4 | $23.6M | Sell |
381,431
-446
| -0.1% | -$27.6K | 0.02% | 705 |
|
2015
Q3 | $15.4M | Sell |
381,877
-15,146
| -4% | -$612K | 0.01% | 837 |
|
2015
Q2 | $22.8M | Sell |
397,023
-153,608
| -28% | -$8.84M | 0.02% | 739 |
|
2015
Q1 | $35.1M | Sell |
550,631
-743
| -0.1% | -$47.3K | 0.02% | 589 |
|
2014
Q4 | $34M | Sell |
551,374
-23,358
| -4% | -$1.44M | 0.02% | 581 |
|
2014
Q3 | $22.3M | Sell |
574,732
-13,156
| -2% | -$511K | 0.02% | 732 |
|
2014
Q2 | $20.3M | Buy |
587,888
+24,688
| +4% | +$851K | 0.01% | 781 |
|
2014
Q1 | $24.3M | Sell |
563,200
-9,001
| -2% | -$389K | 0.02% | 714 |
|
2013
Q4 | $22.8M | Buy |
572,201
+33,432
| +6% | +$1.33M | 0.02% | 737 |
|
2013
Q3 | $20.2M | Buy |
538,769
+16,055
| +3% | +$603K | 0.02% | 745 |
|
2013
Q2 | $14M | Buy |
+522,714
| New | +$14M | 0.01% | 863 |
|